American Journal of Obstetrics & Gynecology
Volume 200, Issue 5 , Pages e24-e26 , May 2009

Rectal misoprostol vs 15-methyl prostaglandin F2α for retained placenta after second-trimester delivery

Presented at the 55th Annual Clinical Meeting of The American College of Obstetricians and Gynecologists, San Diego, CA, May 5-9, 2007.

Received 6 July 2008 ,Revised 19 September 2008 ,Accepted 26 September 2008.

References 

  1. Prata N, Hamza S, Gypson R, Nada K, Vahidnia F, Potts M. Misoprostol and active management of the third stage of labor. Int J Gynaecol Obstet. 2006;94:149–155
  2. Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev. 2004;CD000494
  3. Li YT, Yin CS. Delivery of retained placenta by misoprostol in second trimester abortion. Int J Gynecol Obstet. 2001;74:215–216
  4. Carlan SJ, Gushwa JP, O'Brien WF, Vu Thao . Effect of intramuscular 15-methyl prostaglandin F2 alpha after second trimester delivery. Obstet Gynecol. 1997;89:5–9
  5. Leader J, Bujnovsky M, Carlan SJ, Triana T, Richichi K. Effect of oral misoprostol after second-trimester delivery: a randomized, blinded study. Obstet Gynecol. 2002;100:689–694
  6. Meckstroth KR, Whitaker AK, Bertisch S, Goldberg AB, Darney PD. Misoprostol administered by epithelial routes: drug absorption and uterine response. Obstet Gynecol. 2006;108:582–590
  7. Kirz DS, Hang MK. Management of the third stage of labor in pregnancies terminated by prostaglandin E 2. Am J Obstet Gynecol. 1989;160:412–414

 Authorship and contribution to the article is limited to the 4 authors indicated. There was no outside funding or technical assistance with the production of this article.

PII: S0002-9378(08)01093-4

doi: 10.1016/j.ajog.2008.09.868

American Journal of Obstetrics & Gynecology
Volume 200, Issue 5 , Pages e24-e26 , May 2009

Article Tools